Oragenics Stock Today
| OGEN Stock | USD 1.09 0.03 2.83% |
Performance0 of 100
| Odds Of DistressOver 82
|
Oragenics is selling at 1.09 as of the 25th of April 2024; that is 2.83% increase since the beginning of the trading day. The stock's open price was 1.06. Oragenics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Oragenics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of May 2022 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of February 2004 | Category Healthcare | Classification Health Care |
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida. Oragenics operates under Biotechnology classification in the United States and is traded on AMEX Exchange. The company has 4.48 M outstanding shares of which 41.26 K shares are now shorted by private and institutional investors with about 0.27 trading days to cover. More on Oragenics
Moving against Oragenics Stock
| 0.85 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.81 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.76 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.68 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
| 0.66 | XFOR | X4 Pharmaceuticals Buyout Trend | PairCorr |
| 0.46 | ENVB | Enveric Biosciences Financial Report 20th of May 2024 | PairCorr |
| 0.43 | CGC | Canopy Growth Corp Trending | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Oragenics Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Oragenics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Oragenics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | Alan Joslyn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Oragenics report their recommendations after researching Oragenics' financial statements, talking to executives and customers, or listening in on Oragenics' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Oragenics. The Oragenics consensus assessment is calculated by taking the average forecast from all of the analysts covering Oragenics. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Oragenics' liquidity, profitability, solvency, and operating efficiency, Oragenics is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Oragenics is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oragenics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Oragenics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Oragenics' financial leverage. It provides some insight into what part of Oragenics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oragenics (OGEN) is traded on NYSE MKT Exchange in USA. It is located in 4902 Eisenhower Boulevard, Tampa, FL, United States, 33634 and employs 5 people. Oragenics is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.88 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oragenics's market, we take the total number of its shares issued and multiply it by Oragenics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Oragenics conducts business under Biotechnology sector and is part of Health Care industry. The entity has 4.48 M outstanding shares of which 41.26 K shares are now shorted by private and institutional investors with about 0.27 trading days to cover.
Oragenics currently holds about 17.87 M in cash with (7.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15.
Check Oragenics Probability Of Bankruptcy
Ownership AllocationOragenics has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months.
Check Oragenics Ownership Details
Oragenics Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Oragenics jumping above the current price in 90 days from now is about 82.34%. The Oragenics probability density function shows the probability of Oragenics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Oragenics has a beta of -0.9241. This indicates Additionally, oragenics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Oragenics to move above the current price in 90 days from now is about 82.34 (This Oragenics probability density function shows the probability of Oragenics Stock to fall within a particular range of prices over 90 days) .
Oragenics Historical Income Statement
Oragenics Income Statement is one of the three primary financial statements used for reporting Oragenics's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Oragenics revenue and expense. Oragenics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Oragenics' Interest Expense is very stable compared to the past year. As of the 25th of April 2024, Other Operating Expenses is likely to grow to about 10.7 M, while Depreciation And Amortization is likely to drop about 26 K. View More FundamentalsOragenics Stock Against Markets
Picking the right benchmark for Oragenics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Oragenics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Oragenics is critical whether you are bullish or bearish towards Oragenics at a given time. Please also check how Oragenics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Oragenics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Oragenics Corporate Directors
Oragenics corporate directors refer to members of an Oragenics board of directors. The board of directors generally takes responsibility for the Oragenics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Oragenics' board members must vote for the resolution. The Oragenics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Christine Koski | Independent Director | Profile | |
| Alan Dunton | Independent Director | Profile | |
| Robert Koski | Independent Director | Profile | |
| Charles Pope | Independent Director | Profile |
How to buy Oragenics Stock?
Before investing in Oragenics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Oragenics. To buy Oragenics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Oragenics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Oragenics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Oragenics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Oragenics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Oragenics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Oragenics Stock please use our How to Invest in Oragenics guide.
Already Invested in Oragenics?
The danger of trading Oragenics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Oragenics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Oragenics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Oragenics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Oragenics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oragenics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oragenics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oragenics Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oragenics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.Note that the Oragenics information on this page should be used as a complementary analysis to other Oragenics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Oragenics Stock analysis
When running Oragenics' price analysis, check to measure Oragenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oragenics is operating at the current time. Most of Oragenics' value examination focuses on studying past and present price action to predict the probability of Oragenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oragenics' price. Additionally, you may evaluate how the addition of Oragenics to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Oragenics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oragenics. If investors know Oragenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oragenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.18) | Revenue Per Share 0.017 | Quarterly Revenue Growth (0.91) | Return On Assets (1.32) | Return On Equity (2.55) |
The market value of Oragenics is measured differently than its book value, which is the value of Oragenics that is recorded on the company's balance sheet. Investors also form their own opinion of Oragenics' value that differs from its market value or its book value, called intrinsic value, which is Oragenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oragenics' market value can be influenced by many factors that don't directly affect Oragenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oragenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oragenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oragenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.